🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 12/03/2015 | 0,4294 USD |
| 11/12/2014 | 0,4294 USD |
| 11/09/2014 | 0,4198 USD |
| 12/06/2014 | 0,4198 USD |
| 13/03/2014 | 0,4198 USD |
| 12/12/2013 | 0,4198 USD |
| 12/09/2013 | 0,4103 USD |
| 13/06/2013 | 0,4103 USD |
| 13/03/2013 | 0,4103 USD |
| 13/12/2012 | 0,4103 USD |
| 13/09/2012 | 0,4008 USD |
| 13/06/2012 | 0,4008 USD |
| 13/03/2012 | 0,4008 USD |
| 13/12/2011 | 0,4008 USD |
| 13/09/2011 | 0,3626 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 06/12/1990 | 13,86 | 13,88 | 13,76 | 13,84 | +0,58% | 0,86% | 4.974.437 |
| 05/12/1990 | 13,64 | 13,76 | 13,58 | 13,76 | +0,58% | 1,31% | 3.081.749 |
| 04/12/1990 | 13,58 | 13,76 | 13,42 | 13,68 | +0,73% | 2,49% | 3.108.158 |
| 03/12/1990 | 13,76 | 13,78 | 13,54 | 13,58 | -1,01% | 1,73% | 3.452.741 |
| 30/11/1990 | 13,28 | 13,74 | 13,22 | 13,72 | +2,83% | 3,89% | 6.754.570 |
| 29/11/1990 | 13,36 | 13,40 | 13,24 | 13,34 | -0,44% | 1,19% | 3.821.846 |
| 28/11/1990 | 13,48 | 13,54 | 13,38 | 13,40 | -1,03% | 1,18% | 1.869.422 |
| 27/11/1990 | 13,52 | 13,58 | 13,44 | 13,54 | +0,29% | 1,03% | 3.948.864 |
| 26/11/1990 | 13,22 | 13,50 | 13,20 | 13,50 | +1,19% | 2,26% | 3.351.504 |
| 23/11/1990 | 13,38 | 13,50 | 13,32 | 13,34 | -0,59% | 1,34% | 1.485.854 |
| 21/11/1990 | 13,50 | 13,50 | 13,30 | 13,42 | -0,44% | 1,47% | 4.599.043 |
| 20/11/1990 | 13,58 | 13,64 | 13,46 | 13,48 | -0,88% | 1,32% | 3.926.227 |
| 19/11/1990 | 13,62 | 13,64 | 13,50 | 13,60 | +0,59% | 1,02% | 5.290.094 |
| 16/11/1990 | 13,50 | 13,52 | 13,44 | 13,52 | +0,44% | 0,59% | 6.712.440 |
| 15/11/1990 | 13,38 | 13,50 | 13,32 | 13,46 | +0,30% | 1,34% | 4.910.928 |
| 14/11/1990 | 13,14 | 13,46 | 13,12 | 13,42 | +2,12% | 2,57% | 4.602.816 |
| 13/11/1990 | 13,08 | 13,20 | 13,04 | 13,14 | +0,30% | 1,22% | 3.560.266 |
| 12/11/1990 | 12,88 | 13,12 | 12,86 | 13,10 | +2,33% | 2,01% | 6.255.931 |
| 09/11/1990 | 12,48 | 12,84 | 12,48 | 12,80 | +2,55% | 2,87% | 6.265.363 |
| 08/11/1990 | 12,42 | 12,54 | 12,36 | 12,48 | +0,32% | 1,44% | 7.200.389 |
| 07/11/1990 | 12,56 | 12,70 | 12,42 | 12,44 | -1,26% | 2,22% | 6.718.099 |
| 06/11/1990 | 12,60 | 12,70 | 12,56 | 12,60 | +0,00% | 1,10% | 3.055.968 |
| 05/11/1990 | 12,48 | 12,66 | 12,48 | 12,60 | +1,44% | 1,43% | 3.846.998 |
| 02/11/1990 | 12,29 | 12,48 | 12,27 | 12,42 | +0,81% | 1,78% | 4.666.325 |
| 01/11/1990 | 12,21 | 12,33 | 11,99 | 12,33 | +0,81% | 2,77% | 7.101.667 |
| 31/10/1990 | 12,58 | 12,58 | 12,21 | 12,23 | -2,38% | 3,00% | 4.636.142 |
| 30/10/1990 | 12,46 | 12,58 | 12,36 | 12,52 | +0,64% | 1,75% | 4.217.990 |
| 29/10/1990 | 12,58 | 12,74 | 12,38 | 12,44 | -1,11% | 2,84% | 4.561.315 |
| 26/10/1990 | 12,88 | 12,92 | 12,56 | 12,58 | -3,06% | 2,78% | 3.256.555 |
| 25/10/1990 | 13,06 | 13,10 | 12,86 | 12,98 | -0,30% | 1,83% | 3.932.515 |